NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium

Description

This document in this compendium was contributed by the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium which is part of the Rare Diseases Clinical Research Network (RDCRN; https://www.rarediseasesnetwork.org/). RDCRN is focused on therapeutic developments for amyotrophic lateral sclerosis, frontotemporal dementia, primary lateral sclerosis, hereditary spastic paraplegia, and progressive muscular atrophy. This SOP is available from https://www.rarediseasesnetwork.org/cms/create/researchers/biorepository.

Sources

  • CReATe

SOPs

Title Version (Release Date) Source
BIOSPECIMEN COLLECTION SOP CReATe
Download all SOP documents of selected versions [1]

News and Announcements

  • The Most Downloaded SOPs in 2023

  • New Biobanking for Precision Medicine Seminar

  • New SOP added to the BRD SOP Library!

  • More...